Royalty Pharma plc (MUN:RPD)
34.06
+3.65 (12.00%)
At close: Nov 5, 2025
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of €14.59 billion as of December 5, 2025. Its market cap has increased by 34.54% in one year.
Market Cap
14.59B
Enterprise Value
24.23B
Revenue
2.00B
Ranking
n/a
PE Ratio
22.38
Stock Price
€34.06
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from 14.00B to 14.59B, an increase of 4.22%. That is a compound annual growth rate of 0.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 14.34B | 31.02% |
| Dec 31, 2024 | 10.95B | -3.17% |
| Dec 29, 2023 | 11.31B | -30.69% |
| Dec 30, 2022 | 16.31B | 8.38% |
| Dec 31, 2021 | 15.05B | -5.23% |
| Dec 31, 2020 | 15.88B | 13.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 179.36B |
| Allianz SE | 139.47B |
| Deutsche Telekom AG | 130.38B |
| Siemens Energy AG | 99.77B |
| Rheinmetall AG | 70.66B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.64B |
| Deutsche Bank Aktiengesellschaft | 59.08B |